Trioday - Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tabs

Trioday combines three antiretroviral agents from two drug classes into one tablet, streamlining HIV treatment for many patients. Tenofovir and Lamivudine are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), while Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI); together they act at different stages of viral replication to more effectively suppress HIV-1. This combined action helps reduce viral load, allowing the immune system to recover and CD4 cell counts to improve over time. Being a single-tablet, once-daily regimen, Trioday can make it easier for patients to maintain consistent adherence, which is key to long-term viral suppression. It is generally recommended to be taken on an empty stomach, often at bedtime, to help minimize certain side effects associated with Efavirenz. Regular follow-up with a healthcare provider is important to monitor viral load, CD4 counts, and kidney and liver function during treatment. Many patients using Trioday achieve durable viral suppression and meaningful immune health improvements with consistent use. As with all antiretroviral therapy, it should be taken under the guidance of a healthcare provider as part of a comprehensive HIV care plan.